Monopar Therapeutics(MNPR)内部人交易:高管与董事近期交易
过去 18 个月,共有 13 位内部人为 Monopar Therapeutics(MNPR)报告了 93 笔 Form 4 交易(最近一笔 2026-11-04)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-04 | Tsuchimoto Kim R | 董事 | 买入 | 1,199 | $35,970 |
| 2026-11-04 | Anderson Raymond | 董事 | 买入 | 1,402 | $42,058 |
| 2026-11-04 | Tsuchimoto Kim R | 董事 | 卖出 | 1,199 | $84,050 |
| 2026-11-04 | Anderson Raymond | 董事 | 买入 | 1,740 | $52,200 |
| 2026-11-04 | Tsuchimoto Kim R | 董事 | 买入 | 856 | $25,680 |
| 2026-11-04 | Anderson Raymond | 董事 | 卖出 | 840 | $55,574 |
| 2026-11-04 | Tsuchimoto Kim R | 董事 | 买入 | 2,035 | $28,490 |
| 2026-11-04 | Anderson Raymond | 董事 | 卖出 | 600 | $40,236 |
| 2026-11-04 | Tsuchimoto Kim R | 董事 | 卖出 | 1,295 | $91,621 |
| 2026-11-04 | Anderson Raymond | 董事 | 卖出 | 200 | $13,736 |
| 2026-11-04 | Tsuchimoto Kim R | 董事 | 卖出 | 996 | $71,065 |
| 2026-11-04 | Anderson Raymond | 董事 | 卖出 | 1,502 | $105,200 |
| 2026-11-04 | Tsuchimoto Kim R | 董事 | 卖出 | 600 | $43,326 |
| 2026-10-20 | Robinson Chandler | Chief Executive Officer | 卖出 | 597 | $55,276 |
| 2026-10-05 | STARR CHRISTOPHER M | 董事 | 卖出 | 4,631 | $361,635 |
| 2026-10-05 | STARR CHRISTOPHER M | 董事 | 买入 | 8,400 | $42 |
| 2026-10-05 | STARR CHRISTOPHER M | 董事 | 卖出 | 2,970 | $234,095 |
| 2026-10-05 | STARR CHRISTOPHER M | 董事 | 卖出 | 799 | $63,656 |
| 2026-10-02 | Robinson Chandler | Chief Executive Officer | 买入 | 9,801 | $0 |
| 2026-10-02 | Cittadine Andrew | Chief Operating Officer | 买入 | 4,384 | $0 |
| 2026-10-02 | Vu Quan Anh | Chief Financial Officer | 买入 | 614 | $0 |
| 2026-10-02 | Robinson Chandler | Chief Executive Officer | 卖出 | 4,344 | $346,086 |
| 2026-10-02 | Cittadine Andrew | Chief Operating Officer | 卖出 | 1,944 | $154,878 |
| 2026-10-02 | Vu Quan Anh | Chief Financial Officer | 卖出 | 180 | $14,341 |
| 2026-09-28 | Robinson Chandler | Chief Executive Officer | 买入 | 14,056 | $421,680 |
来源:SEC Form 4 申报文件 · 截至 2026-11-04